Series date: 
01/01/2024 - 12:00am EST to 12/31/2024 - 11:59pm EST

Series Description

This case-based series presents a bi-weekly case review of oncology patients molecular profiling to better understand the clinical application of next generation sequencing and molecular pathways that drive oncogenesis.

Accreditation Statement

The Medical Society of Virginia is a member of the Southern States CME Collaborative, an ACCME Recognized Accreditor. Inova Health System Office of Continuing Medical Education is accredited by the Southern States CME Collaborative to provide continuing medical education for physicians.

Credit Designation Statement

The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 1.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.

ABS Designation Statement

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Disclosure Policy 

Inova Health System’s Office of Continuing Medical Education adheres to ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, program directors, and planners are required to disclose all relevant financial relationships with ineligible entities as defined by ACCME. All relevant conflicts of interest have been mitigated prior to the commencement of this activity.

Series location: 
Inova Schar Cancer Insitute
8095 Innovation Park Drive
Fairfax, VA 22031
United States

Sessions

Session Date
2024 Inova Fairfax Molecular Tumor Board 01/11/2024 01/11/2024 - 12:00pm to 1:00pm EST
2024 Inova Fairfax Molecular Tumor Board 01/25/2024 01/25/2024 - 12:00pm to 1:00pm EST
2024 Inova Fairfax Molecular Tumor Board 02/08/2024 02/08/2024 - 12:00pm to 1:00pm EST
2024 Inova Fairfax Molecular Tumor Board 02/22/2024 02/22/2024 - 12:00pm to 1:00pm EST
2024 Inova Fairfax Molecular Tumor Board 03/14/2024 03/14/2024 - 12:00pm to 1:00pm EDT
2024 Inova Fairfax Molecular Tumor Board 04/11/2024 04/11/2024 - 12:00pm to 1:00pm EDT
2024 Inova Fairfax Molecular Tumor Board 04/25/2024 04/25/2024 - 12:00pm to 1:00pm EDT
2024 Inova Fairfax Molecular Tumor Board 05/09/2024 05/09/2024 - 12:00pm to 1:00pm EDT
2024 Inova Fairfax Molecular Tumor Board 05/23/2024 - 12:00pm to 1:00pm EDT
2024 Inova Fairfax Molecular Tumor Board 06/13/2024 - 12:00pm to 1:00pm EDT

Pages